FDA Inspection 1322676 — David Gary Lott, MD

David Gary Lott, MD — FEI 3043777237

The FDA completed an inspection of David Gary Lott, MD on Jun 11, 2026 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 11, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Phoenix, AZ (United States)

Additional Details

Clinical Investigator (CI)